{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:36:49Z","timestamp":1768714609694,"version":"3.49.0"},"reference-count":23,"publisher":"The Japanese Society for Medical Mycology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2013]]},"DOI":"10.3314\/mmj.54.303","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T23:25:06Z","timestamp":1377818706000},"page":"303-307","source":"Crossref","is-referenced-by-count":15,"title":["Prevalence and Antifungal Susceptibility of Cryptococcus neoformans Isolated from Pigeon Excreta in Chon Buri Province, Eastern Thailand"],"prefix":"10.3314","volume":"54","author":[{"given":"Marut","family":"Tangwattanachuleeporn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poorichaya","family":"Somparn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kulwara","family":"Poolpol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Weig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Bader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1842","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Probst C, Pongratz G, Capellino S, Szeimies RM, Scholmerich J, Fleck M, Salzberger B, Ehrenstein B: Cryptococcosis mimicking cutaneous cellulitis in a patient suffering from rheumatoid arthritis: a case report. BMC Infect Dis 10: 239, 2010.","DOI":"10.1186\/1471-2334-10-239"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Jongwutiwes U, Sungkanuparph S, Kiertiburanakul S: Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients. Jpn J Infect Dis 61(2): 111-115, 2008.","DOI":"10.7883\/yoken.JJID.2008.111"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Girish Kumar CP, Prabu D, Mitani H, Mikami Y, Menon T: Environmental isolation of Cryptococcus neoformans and Cryptococcus gattii from living trees in Guindy National Park, Chennai, South India. Mycoses 53(3): 262-264, 2006.","DOI":"10.1111\/j.1439-0507.2009.01699.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Lin X Heitman J: The biology of the Cryptococcus neoformans species complex. Annu Rev Microbiol 60: 69-105, 2006.","DOI":"10.1146\/annurev.micro.60.080805.142102"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kwon-Chung KL, Boekhout T, Fell JW, Diaz M: Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremenomycetidae). Taxon 51: 804-806, 2002.","DOI":"10.2307\/1555045"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Sriburee P, Khayhan S, Khamwan C, Panjaisee S, Tharavichitkul P: Serotype and PCR-fingerprints of clinical and environmental isolates of Cryptococcus neoformans in Chiang Mai, Thailand. Mycopathologia 158(1): 25-31, 2004.","DOI":"10.1023\/B:MYCO.0000038435.14281.f4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Morera-Lopez Y, Torres-Rodriguez JM, Jimenez-Cabello T, Baro-Tomas T, Alia-Aponte C, Lazera MS: DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples. Mycopathologia 160(1): 9-14, 2005.","DOI":"10.1007\/s11046-005-6332-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Perez C, Dolande M, Moya M, Rosello A, de Capriles CR, Landaeta M E, Mata-Essayag S: Cryptococcus neoformans, Cryptococcus gattii: serotypes in Venezuela. Mycopathologia 166(3): 149-153, 2008.","DOI":"10.1007\/s11046-008-9132-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Nishikawa MM, Lazera MS, Barbosa GG, Trilles L, Balassiano BR, Macedo RC, Bezerra CC, Perez MA, Cardarelli P, Wanke B: Serotyping of 467 Cryptococcus neoformans isolates from clinical and environmental sources in Brazil: analysis of host and regional patterns. J Clin Microbiol 41(1): 73-77, 2003.","DOI":"10.1128\/JCM.41.1.73-77.2003"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kronstad JW, Attarian R, Cadieux B, Choi J, D'Souza CA, Griffiths E J, Geddes J M, Hu G, Jung WH, Kretschmer M, Saikia S, Wang J: Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat Rev Microbiol 9(3): 193-203, 2011.","DOI":"10.1038\/nrmicro2522"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kielstein P, Hotzel H, Schmalreck A, Khaschabi D, Glawischnig W: Occurrence of Cryptococcus spp. in excreta of pigeons and pet birds. Mycoses 43(1-2): 7-15, 2000.","DOI":"10.1046\/j.1439-0507.2000.00534.x"},{"key":"12","unstructured":"12) NCCLs: Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts: Approved Standard M27-A2. NCCLs, ed. n. ed. Vol. 2nd ed. 2002: Wayne, PA."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Lopez-Jodra O, Torres-Rodriguez JM, Mendez-Vasquez R, Ribas-Forcadell E, Morera-Lopez Y, Baro-Tomas T, Alia-Aponte C: In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method. J Antimicrob Chemother 45(5): 645-649, 2000.","DOI":"10.1093\/jac\/45.5.645"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Arechavala AI, Ochiuzzi ME, Borgnia MD, Santiso GM: Fluconazole and amphotericin B susceptibility testing of Cryptococcus neoformans: results of minimal inhibitory concentrations against 265 isolates from HIV-positive patients before and after two or more months of antifungal therapy. Rev Iberoam Micol 26(3): 194-197, 2009.","DOI":"10.1016\/j.riam.2009.02.001"},{"key":"15","unstructured":"15) Soogarun S, Wiwanitkit V, Palasuwan A, Pradniwat P, Suwansaksri J, Lertlum T, Maungkote T: Detection of Cryptococcus neoformans in bird excreta. Southeast Asian J Trop Med Public Health 37(4): 768-770, 2006."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Liaw SJ, Wu HC, Hsueh PR: Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility. Clin Microbiol Infect 16(6): 696-703, 2010.","DOI":"10.1111\/j.1469-0691.2009.02930.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Day JN, Hoang TN, Duong AV, Hong CT, Diep PT, Campbell JI, Sieu TP, Hien TT, Bui T, Boni MF, Lalloo DG, Carter D, Baker S, Farrar JJ: Most cases of cryptococcal meningitis in HIV-uninfected patients in Vietnam are due to a distinct amplified fragment length polymorphism-defined cluster of Cryptococcus neoformans var. grubii VN1. J Clin Microbiol 49(2): 658-664, 2011.","DOI":"10.1128\/JCM.01985-10"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Archibald LK, Tuohy MJ, Wilson DA, Nwanyanwu O, Kazembe PN, Tansuphasawadikul S, Eampokalap B, Chaovavanich A, Reller LB, Jarvis WR, Hall GS, Procop GW: Antifungal susceptibilities of Cryptococcus neoformans. Emerg Infect Dis 10(1): 143-145, 2004.","DOI":"10.3201\/eid1001.020779"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Poonwan N, Mikami Y, Poosuwan S, Boon-Long J, Mekha N, Kusum M, Yazawa K, Tanaka R, Nishimura K, Konyama K: Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents. Eur J Epidemiol 13(3): 335-340, 1997.","DOI":"10.1023\/A:1007376917836"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Sar B, Monchy D, Vann M, Keo C, Sarthou JL, Buisson Y: Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002. J Antimicrob Chemother 54(2): 563-565, 2004.","DOI":"10.1093\/jac\/dkh361"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Tan AL, Chan KS: In vitro activities of antifungal drugs against yeasts isolated from blood cultures and moulds isolated from various clinically significant sites in Singapore. Ann Acad Med Singapore 37(10): 841-846, 2008.","DOI":"10.47102\/annals-acadmedsg.V37N10p841"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Pfaller MA, Zhang J, Messer SA, Brandt ME, Hajjeh RA, Jessup CJ, Tumberland M, Mbidde EK, Ghannoum MA: In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother 43(1): 169-171, 1999.","DOI":"10.1128\/AAC.43.1.169"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Tay ST, Rohani MY, Hoo TS, Hamimah H: Epidemiology of cryptococcosis in Malaysia. Mycoses 53(6): 509-514, 2010.","DOI":"10.1111\/j.1439-0507.2009.01750.x"}],"container-title":["Medical Mycology Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T05:44:29Z","timestamp":1688449469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/54\/3\/54_303\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.54.303","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}